HomeAVDL • NASDAQ
add
Avadel Pharmaceuticals PLC
Previous close
$15.80
Day range
$15.63 - $18.41
Year range
$6.38 - $18.41
Market cap
1.74B USD
Avg Volume
1.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 68.13M | 64.15% |
Operating expense | 52.88M | 2.76% |
Net income | 9.66M | 169.92% |
Net profit margin | 14.19 | 142.61% |
Earnings per share | 0.10 | 171.43% |
EBITDA | 9.95M | 180.88% |
Effective tax rate | -48.81% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 81.55M | 14.24% |
Total assets | 187.16M | 18.81% |
Total liabilities | 96.45M | 10.56% |
Total equity | 90.71M | — |
Shares outstanding | 97.10M | — |
Price to book | 16.81 | — |
Return on assets | 12.51% | — |
Return on capital | 18.26% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 9.66M | 169.92% |
Cash from operations | 12.70M | 169.82% |
Cash from investing | -8.25M | -178.24% |
Cash from financing | 982.00K | 35.82% |
Net change in cash | 7.03M | 201.22% |
Free cash flow | 8.27M | 141.29% |
About
Founded
2015
Website
Employees
188
